Altre lingue Horizon Discovery Group plc

Azioni

HZD

GB00BK8FL363

Tempo differito London S.E. Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^GBX	-.--%		-.--%	+23,00%

2022	Il Medical Device Innovation Consortium (MDIC) collabora con Horizon Discovery di PerkinElmer per migliorare l'accuratezza della diagnostica del cancro basata sul sequenziamento di nuova generazione.	CI
2020	Horizon Discovery sale del 110% con l'acquisizione da parte di PerkinElmer in un affare da 366 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Medical Device Innovation Consortium Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics	19/10/22
Horizon Discovery : Acquisition by PerkinElmer Completes	23/12/20
PerkinElmer (UK) Holdings Ltd. completed the acquisition of Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others.	23/12/20
Horizon Discovery : Takeover by PerkinElmer Gets Court Approval	22/12/20
GFGW LLC : - Form 8.3 - Horizon Discovery Group Plc	11/12/20
Horizon Discovery : Soars 110% on Acquisition by PerkinElmer in $366 Million Deal	02/11/20
PerkinElmer (UK) Holdings Ltd. agreed to acquire Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others for approximately £290 million.	02/11/20
Horizon Discovery Group plc Reports Earnings Results for the Half Year Ended June 30, 2020	17/08/20
Horizon Discovery : introduces single cell RNAseq-linked CRISPR screening service	04/08/20
Horizon Discovery Group plc Announces the Addition of Single Cell RNAseq-Linked Pooled CRISPR Screening to Its CRISPR Screening Services Portfolio	04/08/20
Horizon Discovery : Licenses CHOSOURCE Platform to Truebinding for Development and Commercialization of Multiple Biotherapeutics	29/07/20
Horizon Discovery Group plc Licenses Chosource Platform to TrueBinding, Inc for Development and Commercialization of Multiple Biotherapeutics	29/07/20
Horizon Discovery Group plc Provides Group Revenue Guidance for the Six Months Ended June 30, 2020	29/07/20
Horizon Discovery : Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07/07/20
Horizon Discovery Group plc Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07/07/20
Horizon Discovery : Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19/05/20
Rentschler Biopharma Licenses Horizon Discovery's Chosource Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19/05/20
Horizon Discovery Group plc Announces Board Changes	01/05/20
Horizon Discovery : Full Year Unaudited Results 2019	27/04/20
Horizon Discovery Group plc Unable to Provide Guidance for the Full Year of 2020	27/04/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Horizon Discovery Group plc

Azioni

HZD

GB00BK8FL363

Altre lingue

Filtri